Skip to main content
Clinical Trials/NCT04150003
NCT04150003
Unknown
Not Applicable

Multicenter, Randomize Study to Evaluate the Effect of a Physical Training Structured Program After a Pulmonary Thromboembolism in the Restoration Lung Perfusion

Fundación Pública Andaluza para la gestión de la Investigación en Sevilla3 sites in 1 country144 target enrollmentNovember 1, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pulmonary Embolism
Sponsor
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Enrollment
144
Locations
3
Primary Endpoint
Change in the rate of lung perfusion defects after PE
Last Updated
5 years ago

Overview

Brief Summary

Exercise training, as the core component of a Pulmonary Rehabilitation program, may help restore arterial blood flow in the lungs of patients who had suffered Pulmonary Embolism (PE), stimulating and promoting vasodilator effects, repairing the damaged endothelium and recruiting new blood vessels and also inducing a net fibrinolytic balance. Besides, exercise training could have a positive effect on quality of life of these patients.

Detailed Description

An experimental multicenter study is proposed , randomized according to parallel assignation and blinded to third ones to evaluate the effect of a 10-weeks structured exercise-based intervention protocol on the restoration of lung blood flow after an acute PE. Main objective is to compare the efficacy and safety in terms of quantitative measures from lung scintigraphy, of lung perfusion versus usual care in patients with PE. Additionally the study is aimed to identify bio-markers of response to treatment (mRNAs, MPs and proteomic approach) and to analyze the effects of training on exercise capacity, quality of life parameters and anxiety depression scores.

Registry
clinicaltrials.gov
Start Date
November 1, 2019
End Date
January 1, 2022
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients 18 years or older at PE diagnosis PE diagnosis confirmed by imaging tests according guidelines Patients under correct anticoagulant treatment Persistent Lung Perfusion Defects at one month after PE diagnosis. Signed Consent Inform

Exclusion Criteria

  • Incidental or silent PE Pregnant or puerperal woman Life expectancy less than 6 months Severe comorbidities (NYHA 4 in severe heart failure; COPD, gold D; severe psychiatric illness) Any disability for physical exercise according to their doctors

Outcomes

Primary Outcomes

Change in the rate of lung perfusion defects after PE

Time Frame: Baseline up to one month after the episode of PE, final after 12 weeks of randomization

Lung scintigraphy of lung perfusion

Secondary Outcomes

  • Identification of another biomarkers of response to treatment(The day the randomization occurs and the final visit after 12 weeks of the randomization)
  • Change in the percent predicted peak oxygen uptake (VO2 peak) after PE(Baseline up to one month after the episode of PE, final after 12 weeks of randomization)
  • Identification of biomarkers of response to treatment(The day the randomization occurs and the final visit after 12 weeks of the randomization)
  • Change in the EuroQol scale(Baseline up to one month after the episode of PE, final after 12 weeks of randomization)
  • Change in the PEmb-QoL questionnaire by a PEmb-QoL -("Baseline up to one month after the episode of PE, final after 12 weeks of randomization)

Study Sites (3)

Loading locations...

Similar Trials